Jasper Therapeutics, Inc.

Develops mast cell-depleting antibody therapies for chronic diseases and stem cell transplants.

JSPR | NDAQ

Overview

Corporate Details

ISIN(s):: US4718712023 (+3 more)
LEI:
Country:: United States of America
Address:: 2200 BRIDGE PKWY SUITE #102, 94065 REDWOOD CITY
Website:: https://jaspertx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for mast cell-driven diseases and as a conditioning agent for hematopoietic stem cell transplantation. The company's lead product candidate is briquilimab, a targeted anti-KIT (CD117) monoclonal antibody designed to deplete mast cells. Jasper is evaluating briquilimab in clinical studies for the treatment of chronic immunological and inflammatory diseases, including chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), and allergic asthma. The company's mission is to develop safer and more effective therapies for patients with serious chronic diseases by harnessing the power of mast cell depletion.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Jasper Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Jasper Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Jasper Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
DaehanPharmaceutical Develops and manufactures pharmaceuticals and health foods for human and animal markets worldwide.	South Korea	023910
Daesung Microbiological Labs. Co. Ltd Researches and manufactures veterinary vaccines and medicines for livestock, fish, and canines.	South Korea	036480
DAEWOONG PHARMA A global R&D partner for drug development, manufacturing, and commercialization services.	South Korea	069620
DAIICHI SANKYO COMPANY, LIMITED A global pharmaceutical firm developing novel therapies with a focus on oncology and ADCs.	Japan	4568
Daito Pharmaceutical Co., Ltd. Manufactures APIs, generic drugs, and health foods; provides contract manufacturing services.	Japan	4577
Dare Bioscience, Inc. Advancing innovative therapies for women's health in contraception, fertility, and sexual health.	United States of America	DARE
Day One Biopharmaceuticals, Inc. Developing targeted cancer therapies for all ages, with a focus on pediatric oncology.	United States of America	DAWN
DBV Technologies S.A. Developing non-invasive skin patch immunotherapies for food allergies and immune diseases.	United States of America	DBVT
D&D Pharmatech Inc. Develops oral & injectable peptide therapies for metabolic & chronic diseases like obesity.	South Korea	347850
Dechra Pharmaceuticals PLC Develops & sells veterinary pharmaceuticals for companion animals, exclusively to veterinarians.	United Kingdom	DPH